ATE114470T1 - Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung. - Google Patents

Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.

Info

Publication number
ATE114470T1
ATE114470T1 AT91304574T AT91304574T ATE114470T1 AT E114470 T1 ATE114470 T1 AT E114470T1 AT 91304574 T AT91304574 T AT 91304574T AT 91304574 T AT91304574 T AT 91304574T AT E114470 T1 ATE114470 T1 AT E114470T1
Authority
AT
Austria
Prior art keywords
treatment
synergistic combination
intraocular pressure
ophthalmic use
lowerlakylprostaglandin
Prior art date
Application number
AT91304574T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE114470T1 publication Critical patent/ATE114470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91304574T 1990-05-22 1991-05-21 Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung. ATE114470T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13290990 1990-05-22

Publications (1)

Publication Number Publication Date
ATE114470T1 true ATE114470T1 (de) 1994-12-15

Family

ID=15092362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91304574T ATE114470T1 (de) 1990-05-22 1991-05-21 Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.

Country Status (8)

Country Link
US (1) US5208256A (de)
EP (1) EP0458588B1 (de)
JP (1) JPH0798751B2 (de)
AT (1) ATE114470T1 (de)
CA (1) CA2042972C (de)
DE (1) DE69105349T2 (de)
DK (1) DK0458588T3 (de)
ES (1) ES2067864T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
WO1998050024A1 (en) * 1997-05-09 1998-11-12 The Mount Sinai School Of Medicine Of The City University Of New York 8-iso-prostaglandins for glaucoma therapy
KR20040008174A (ko) * 2001-05-14 2004-01-28 수캄포 아게 고안압증 및 녹내장 치료방법
WO2003018025A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma
US8580851B2 (en) * 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
EP1985298A1 (de) 2007-04-24 2008-10-29 Azad Pharma AG Prostaglandinhaltige Öl-in-Wasser-Emulsionen für das Auge
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
JP2014510762A (ja) * 2011-04-12 2014-05-01 ポリアクティヴァ・プロプライエタリー・リミテッド ポリマーにコンジュゲートしたプロスタグランジン類似体
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062964A (en) * 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
JPS52154528A (en) * 1976-05-31 1977-12-22 Kaken Pharmaceut Co Ltd Remedy for glaucoma
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
US4822820A (en) * 1986-11-24 1989-04-18 Alcon Laboratories, Inc. Use of tri-methyl PG-F2 a and derivatives in glaucoma therapy
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
EP0366279B1 (de) * 1988-10-01 1994-09-21 R-Tech Ueno Ltd. Okulare hypotensive Mittel

Also Published As

Publication number Publication date
JPH04253910A (ja) 1992-09-09
DE69105349D1 (de) 1995-01-12
EP0458588B1 (de) 1994-11-30
EP0458588A1 (de) 1991-11-27
CA2042972A1 (en) 1991-11-23
JPH0798751B2 (ja) 1995-10-25
DE69105349T2 (de) 1995-04-06
DK0458588T3 (da) 1995-03-13
US5208256A (en) 1993-05-04
ES2067864T3 (es) 1995-04-01
CA2042972C (en) 1996-10-15

Similar Documents

Publication Publication Date Title
DE69105349D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
DE69434228D1 (de) Verwendung von Fluprostenolisopropylester zur Herstellung eines Arzneimittels zur Behandlung von Glaukom und okularer Hypertension
DE69129921D1 (de) Behandlung von Katarakt mit 15-keto-Prostaglandinderivaten
EP0276317A4 (de) Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten.
ATE121295T1 (de) Augentropfenarzneimittel.
ES2059375T3 (es) Utilizacion del tetrahidrocortisol en la terapia del glaucoma.
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
DE68918099D1 (de) Pharmazeutische behandlung einer augenentwicklung.
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
EP0069089A3 (en) Intraocular lens
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69210286D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE108331T1 (de) Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
SU648187A1 (ru) Состав дл консервировани роговиц человека
DK0514009T3 (da) Hornhindebehandlingsmiddel
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
ATE88903T1 (de) Parenteral applizierbares lagerbestaendiges immunstimulierendes praeparat, verfahren zu seiner herstellung und dessen verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time